Literature DB >> 25309804

Further phenotypic expansion of 15q11.2 BP1-BP2 microdeletion (Burnside-Butler) syndrome.

Adria M Jerkovich1, Merlin G Butler2.   

Abstract

We report a 10-year-old Caucasian male identified with copy number variation detected by microarray analysis including a maternally inherited 15q11.2 microdeletion involving 4 genes, paternally inherited 13q12.2 microdeletion with 10 genes, and a de novo 2q14.3 duplication involving 4 genes. He had a history of speech delay, cognitive deficits, attention deficit hyperactivity disorder and a posterior lenticonus cataract removed at 5 yr of age. The genes on chromosomes 2 and 13 are not known to be involved with cataract formation, which lends further support of the role of the 15q11.2 region and additional evidence for phenotypic expansion of the 15q11.2 BP1-BP2 microdeletion (termed Burnside-Butler) syndrome.

Entities:  

Keywords:  Microarray analysis; congenital cataracts; dysmorphic features; motor and language delay

Year:  2014        PMID: 25309804      PMCID: PMC4190059          DOI: 10.3233/PGE-14082

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  7 in total

Review 1.  Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.

Authors:  M G Butler
Journal:  J Intellect Disabil Res       Date:  2017-04-07

Review 2.  The 15q11.2 BP1-BP2 microdeletion syndrome: a review.

Authors:  Devin M Cox; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2015-02-13       Impact factor: 5.923

Review 3.  Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.

Authors:  M A Angulo; M G Butler; M E Cataletto
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

Review 4.  The 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Phenotypes.

Authors:  Syed K Rafi; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

5.  Adverse Perinatal and Early Life Outcomes following 15q11.2 CNV Diagnosis.

Authors:  Fu-Chieh Chu; Steven W Shaw; Chien-Hong Lee; Liang-Ming Lo; Jenn-Jeih Hsu; Tai-Ho Hung
Journal:  Genes (Basel)       Date:  2021-09-23       Impact factor: 4.096

6.  Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients.

Authors:  Teresa Giugliano; Marco Savarese; Arcomaria Garofalo; Esther Picillo; Chiara Fiorillo; Adele D'Amico; Lorenzo Maggi; Lucia Ruggiero; Liliana Vercelli; Francesca Magri; Fabiana Fattori; Annalaura Torella; Manuela Ergoli; Anna Rubegni; Marina Fanin; Olimpia Musumeci; Jan De Bleecker; Lorenzo Peverelli; Maurizio Moggio; Eugenio Mercuri; Antonio Toscano; Marina Mora; Lucio Santoro; Tiziana Mongini; Enrico Bertini; Claudio Bruno; Carlo Minetti; Giacomo Pietro Comi; Filippo Maria Santorelli; Corrado Angelini; Luisa Politano; Giulio Piluso; Vincenzo Nigro
Journal:  Genes (Basel)       Date:  2018-10-26       Impact factor: 4.096

7.  Prenatal diagnosis of a de novo 15q11.2 microdeletion in a maternal inv(4)(p15q31) fetus with increased nuchal translucency: A case report and literature review.

Authors:  Meiling Sun; Fagui Yue; Yang Yu; Leilei Li; Yuting Jiang; Hongguo Zhang; Ruizhi Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.